C12N 2770/38022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/38022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 7 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 10
- Assignees
- 11
- Inventors
- 35
- Latest grant
- 21 Nov 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 2 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nanoparticles and biotemplates with tunable length and methods of manufacturing the same21 Nov 2023US 11,820,988 B2Purdue Research Foundation
- Simultaneous gene silencing and suppressing gene silencing in ihe same cell24 Jan 2023US 11,560,571 B2Commonwealth Scientific and Industrial Research Organisation
- Simultaneous gene silencing and suppressing gene silencing in the same cell3 Nov 2020US 10,822,615 B2Commonwealth Scientific and Industrial Research Organisation
- Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds13 Feb 2007US 7,175,984 B2
- Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding25 May 2004US 6,740,490 B2Kansas State University Research Foundation
- Engineered Plant Virus-Based Nanoparticles and Intravenous Formulations Thereof for Autoimmune Therapy16 Jul 2026US 2026/0199518 A1
- Artificial viral capsid19 Feb 2026US 2026/0049107 A1AGC Inc.
- Use of interferon as an adjuvant in vaccines20 Feb 2025US 2025/0057946 A1Zoetis Services LLC
- Inclusion body mediated method for double-stranded rna producing7 Nov 2024US 2024/0368657 A1Xiaomo Biotech Limited
- Simultaneous gene silencing and suppressing gene silencing in the same cell15 Apr 2021US 2021/0108220 A1Commonwealth Scientific and Industrial Research Organisation
Most cited
By later US patents
- Genetics manipulations with recombinant DNA virus comprising sequences derived from RNA virus6US 6,093,554 AAveve N.V. · 2000
- Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus4US 6,197,542 B1Aveve N.V. · 2001
- Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds1US 7,175,984 B22007